NOVAVAX INC Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Novavax Inc quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Novavax Inc Cost of Revenue for the quarter ending September 30, 2024 was $60.6M, a 38.7% decline year-over-year.
  • Novavax Inc Cost of Revenue for the twelve months ending September 30, 2024 was $321M, a 13.4% decline year-over-year.
  • Novavax Inc annual Cost of Revenue for 2023 was $344M, a 61.9% decline from 2022.
  • Novavax Inc annual Cost of Revenue for 2022 was $903M.
  • Novavax Inc annual Cost of Revenue for 2021 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $344M -$559M -61.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $903M +$903M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.